Docking, virtual high throughput screening and in silico fragment-based drug design

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 2, 2009, Pages 238-248

  Zoete, Vincent ^a   Grosdidier, Aurélien ^a   Michielin, Olivier ^a,b,c  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^c Multidisciplinary Oncology Center (CePO)   (Switzerland)

Author keywords

Docking; Fragment based drug design; Virtual high throughput screening

Indexed keywords

LIGAND;

ALGORITHM; ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; DRUG DESIGN; DRUG SCREENING; HUMAN; METHODOLOGY; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 61349165523     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00665.x     Document Type: Article

References (109)

1. Jorgensen WL. The many roles of computation in drug discovery. Science. 2004 303 : 1813 8.
2. Grosdidier A, Zoete V, Michielin O. EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization. Proteins. 2007 67 : 1010 25.
3. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE. A geometric approach to macromolecule-ligand interactions. J Mol Biol. 1982 161 : 269 88.
4. Kontoyianni M, Madhav P, Suchanek E, Seibel W. Theoretical and practical considerations in virtual screening: a beaten field Curr Med Chem. 2008 15 : 107 16.
5. Sousa SF, Fernandes PA, Ramos MJo. Protein-ligand docking: current status and future challenges. Proteins. 2006 65 : 15 26.
6. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004 3 : 935 49.
7. Brooijmans N, Kuntz ID. Molecular recognition and docking algorithms. Annu Rev Biophys Biomol Struct. 2003 32 : 335 73.
8. Taylor RD, Jewsbury PJ, Essex JW. A review of protein-small molecule docking methods. J Comput Aided Mol Des. 2002 16 : 151 66.
9. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry. 1998 19 : 1639 62.
10. Huey R, Morris GM, Olson AJ, Goodsell DS. A semiempirical free energy force field with charge-based desolvation. J Comput Chem. 2007 28 : 1145 52.
11. Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997 267 : 727 48.
12. Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD. Improved protein-ligand docking using GOLD. Proteins. 2003 52 : 609 23.
13. Rarey M, Kramer B, Lengauer T, Klebe G. A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 1996 261 : 470 89.
14. Claussen H, Buning C, Rarey M, Lengauer T. FlexE: efficient molecular docking considering protein structure variations. J Mol Biol. 2001 308 : 377 95.
15. Ewing TJ, Makino S, Skillman AG, Kuntz ID. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des. 2001 15 : 411 28.
16. Abagyan R, Totrov M, Kuznetsov D. ICM†-†A new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. Journal of Computational Chemistry. 1994 15 : 488 506.
17. Cavasotto CN, Abagyan RA. Protein flexibility in ligand docking and virtual screening to protein kinases. J Mol Biol. 2004 337 : 209 25.
18. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004 47 : 1739 49.
19. Welch W, Ruppert J, Jain AN. Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites. Chem Biol. 1996 3 : 449 62.
20. McMartin C, Bohacek RS. QXP: powerful, rapid computer algorithms for structure-based drug design. J Comput Aided Mol Des. 1997 11 : 333 44.
21. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004 47 : 1750 9.
22. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006 49 : 6177 96.
23. Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem. 2006 49 : 3315 21.
24. Metropolis N, Rosenbluth AW, Rosenbluth AH, Teller AH, Teller E. Equations of State Calculations by Fast Computing Machines. J Chem Phys. 1953 21 : 1087 92.
25. Muegge I, Martin YC. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem. 1999 42 : 791 804.
26. Gohlke H, Hendlich M, Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol. 2000 295 : 337 56.
27. Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP. Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J Comput Aided Mol Des. 1998 12 : 309 23.
28. Eldridge MD. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des. 1997 11 : 425 45.
29. Zou X, Yaxiong S, Kuntz ID. Inclusion of solvation in ligand binding free energy calculations using the generalized-born model. J. Am. Chem. Soc. 1999 121 : 8033 43.
30. Lee MS, Salsbury FR, Brooks CL. Novel generalized Born methods. Journal of Chemical Physics. 2002 116 : 10606 14.
31. Lee MS, Feig M, Salsbury FR, Brooks CL. New analytic approximation to the standard molecular volume definition and its application to generalized born calculations. Journal of Computational Chemistry. 2003 24 : 1348 56.
32. Roche O, Kiyama R, Brooks CL. Ligand-protein database: linking protein-ligand complex structures to binding data. J Med Chem. 2001 44 : 3592 8.
33. Nissink JWM, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R. A new test set for validating predictions of pro-tein-ligand interaction. Proteins. 2002 49 : 457 71.
34. Hartshorn MJ, Verdonk ML, Chessari G, Brewerton SC, Mooij WTM, Mortenson PN, Murray CW. Diverse, high-quality test set for the validation of protein-ligand docking performance. J Med Chem. 2007 50 : 726 41.
35. Hu L, Benson ML, Smith RD, Lerner MG, Carlson HA. Binding MOAD (Mother Of All Databases). Proteins. 2005 60 : 333 40.
36. Cole JC, Murray CW, Nissink JWM, Taylor RD, Taylor R. Comparing protein-ligand docking programs is difficult. Proteins: Struct Funct Bioinform. 2005 60 : 325 32.
37. Kellenberger E, Rodrigo J, Muller P, Rognan D. Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins. 2004 57 : 225 42.
38. Westhead DR, Clark DE, Murray CW. A comparison of heuristic search algorithms for molecular docking. J Comput Aided Mol Des. 1997 11 : 209 28.
39. Bursulaya BD, Totrov M, Abagyan R, Brooks CL. Comparative study of several algorithms for flexible ligand docking. J Comput Aided Mol Des. 2003 17 : 755 63.
40. Verdonk ML, Mortenson PN, Hall RJ, Hartshorn MJ, Murray CW. Protein-ligand docking against non-native protein con-formers. J Chem Inf Model. 2008.
41. Warren GL, Andrews CW, Capelli A-M, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS. A critical assessment of docking programs and scoring functions. J Med Chem. 2006 49 : 5912 31.
42. Schulz-Gasch T, Stahl M. Binding site characteristics in structure-based virtual screening: evaluation of current docking tools. J Mol Model. 2003 9 : 47 57.
43. Wang R, Lu Y, Wang S. Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem. 2003 46 : 2287 303.
44. McInnes C. Virtual screening strategies in drug discovery. Curr Opin Chem Biol. 2007 11 : 494 502.
45. Schneider G. Trends in virtual combinatorial library design. Curr Med Chem. 2002 9 : 2095 101.
46. Klebe G. Virtual ligand screening: strategies, perspectives and limitations. Drug Discovery Today. 2006 11 : 580 94.
47. Kurogi Y, Güner OF. Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. Curr Med Chem. 2001 8 : 1035 55.
48. Rarey M, Dixon JS. Feature trees: a new molecular similarity measure based on tree matching. J Comput Aided Mol Des. 1998 12 : 471 90.
49. Alvarez JC. High-throughput docking as a source of novel drug leads. Curr Opin Chem Biol. 2004 8 : 365 70.
50. Ghosh S, Nie A, An J, Huang Z. Structure-based virtual screening of chemical libraries for drug discovery. Curr Opin Chem Biol. 2006 10 : 194 202.
51. Kolb P, Huang D, Dey F, Caflisch A. Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model. J Med Chem. 2008 51 : 1179 88.
52. Scarsi M, Podvinec M, Roth A, Hug H, Kersten S, Albrecht H, Schwede T, Meyer UA, Rücker C. Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach. Mol Pharmacol. 2007 71 : 398 406.
53. Kraemer O, Hazemann I, Podjarny AD, Klebe G. Virtual screening for inhibitors of human aldose reductase. Proteins. 2004 55 : 814 23.
54. Lu IL, Mahindroo N, Liang PH, Peng YH, Kuo CJ, Tsai K-C, Hsieh H-P, Chao Y-S, Wu S-Y. Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease. J Med Chem. 2006 49 : 5154 61.
55. Lu Y, Nikolovska-Coleska Z, Fang X, Gao W, Shangary S, Qiu S, Qin D, Wang S. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. J Med Chem. 2006 49 : 3759 62.
56. Lahana R. How many leads from HTS? Drug Discov Today. 1999 4 : 447 8.
57. Carr RAE, Congreve M, Murray CW, Rees DC. Fragment-based lead discovery: leads by design. Drug Discov Today. 2005 10 : 987 92.
58. Erlanson DA, Jahnke W. Fragment-based approches in drug discovery. In : Jahnke W, Erlanson DA, editors. Wiley-VCH, Weinheim, Germany, 2006.
59. Schneider G, Fechner U. Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov. 2005 4 : 649 63.
60. Congreve M, Chessari G, Tisi D, Woodhead AJ. Recent developments in fragment-based drug discovery. J Med Chem. 2008 51 : 3661 80.
61. Bohacek RS, McMartin C, Guida WC. The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev. 1996 16 : 3 50.
62. Dobson CM. Chemical space and biology. Nature. 2004 432 : 824 8.
63. Lipinski C, Hopkins A. Navigating chemical space for biology and medicine. Nature. 2004 432 : 855 61.
64. Walters WP, Stahl MT, Murcko MA. Virtual screening - an overview. Drug Discov Today. 1998 3 : 160 78.
65. Hann MM, Oprea TI. Pursuing the leadlike-ness concept in pharmaceutical research. Curr Opin Chem Biol. 2004 8 : 255 63.
66. Fink T, Bruggesser H, Reymond J-L. Virtual exploration of the small-molecule chemical universe below 160 Daltons. Angew Chem Int Ed Engl. 2005 44 : 1504 8.
67. Hann MM, Leach AR, Harper G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci. 2001 41 : 856 64.
68. Murray CW, Verdonk ML. Fragment-based approaches in drug discovery. In : Jahnke W, Erlanson DA, editors. Wiley-VCH, Weinheim, Germany, 2006.
69. Congreve M, Carr R, Murray C, Jhoti H. A 'rule of three' for fragment-based lead discovery? Drug Discov Today. 2003 8 : 876 77.
70. Bemis GW, Murcko MA. The properties of known drugs. 1. Molecular frameworks. J Med Chem. 1996 39 : 2887 93.
71. Bemis GW, Murcko MA. Properties of known drugs. 2. Side chains. J Med Chem. 1999 42 : 5095 9.
72. Mauser H, Stahl M. Chemical fragment spaces for de novo design. J Chem Inf Model. 2007 47 : 318 24.
73. Vieth M, Siegel MG, Higgs RE, Watson IA, Robertson DH, Savin KA, Durst GL, Hipskind PA. Characteristic physical properties and structural fragments of marketed oral drugs. J Med Chem. 2004 47 : 224 32.
74. Kolb, Caflisch A. Automatic and efficient decomposition of two-dimensional structures of small molecules for fragment-based high-throughput docking. J Med Chem. 2006 49 : 7384 92.
75. Böhm HJ. The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des. 1992 6 : 61 78.
76. Miranker A, Karplus M. Functionality maps of binding sites: a multiple copy simultaneous search method. Proteins. 1991 11 : 29 34.
77. Eisen MB, Wiley DC, Karplus M, Hubbard RE. HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins. 1994 19 : 199 221.
78. Clark DE, Frenkel D, Levy SA, Li J, Murray CW, Robson B, Waszkowycz B, Westhead DR. PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules. J Comput Aided Mol Des. 1995 9 : 13 32.
79. Wang R, Gao Y, Lai L. LigBuilder: A multipurpose program for structure-based drug design. J Mol Model. 2000 6 : 498 516.
80. Caflisch A. Computational combinatorial ligand design: application to human alphathrombin. J Comput Aided Mol Des. 1996 10 : 372 96.
81. Dey F, Caflisch A. Fragment-based de novo ligand design by multiobjective evolutionary optimization. J Chem Inf Model. 2008 48 : 679 90.
82. Douguet D, Munier-Lehmann H, Labesse G, Pochet S. LEA3D: a computer-aided lig-and design for structure-based drug design. J Med Chem. 2005 48 : 2457 68.
83. Majeux N, Scarsi M, Caflisch A. Efficient electrostatic solvation model for protein-fragment docking. Prot-Struct Funct Genet. 2001 42 : 256 68.
84. Alig L, Alsenz J, Andjelkovic M, Bendels S, Bénardeau A, Bleicher K, Bourson A, David-Pierson P, Guba W, Hildbrand S, Kube D, Lübbers T, Mayweg AV, Narquizian R, Neidhart W, Nettekoven M, Plancher J-M, Rocha C, Rogers-Evans M, Röver S, Schneider G, Taylor S, Waldmeier P. Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity. J Med Chem. 2008 51 : 2115 27.
85. Firth-Clark S, Willems HMG, Williams A, Harris W. Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen. J Chem Inf Model. 2006 46 : 642 47.
86. Jorgensen WL, Ruiz-Caro J, Tirado-Rives J, Basavapathruni A, Anderson KS, Hamilton AD. Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg Med Chem Lett. 2006 16 : 663 7.
87. Pierce AC, Rao G, Bemis GW. BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease. J Med Chem. 2004 47 : 2768 75.
88. Vinkers HM, de Jonge MR, Daeyaert FFD, Heeres J, Koymans LMH, van Lenthe JH, Lewi PJ, Timmerman H, Aken KV, Janssen PAJ. Synopsis: synthesize and optimize system in silico. J Med Chem. 2003 46 : 2765 73.
89. Honma T, Hayashi K, Aoyama T, Hashimoto N, Machida T, Fukasawa K, Iwama T, Ikeura C, Ikuta M, Suzuki-Takahashi I, Iwasawa Y, Hayama T, Nishimura S, Morishima H. Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design. J Med Chem. 2001 44 : 4615 27.
90. Böhm HJ, Banner DW, Weber L. Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors. J Comput Aided Mol Des. 1999 13 : 51 6.
91. Lewell XQ, Judd DB, Watson SP, Hann MM. RECAP-retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci. 1998 38 : 511 22.
92. Gillet V, Myatt G, Zsoldos Z, Johnson A. SPROUT, HIPPO and CAESA: Tools for de novo structure generation and estimation of synthetic accessibility. Perspect Drug Discov Design. 1995 3 : 34 50.
93. Boda K, Seidel T, Gasteiger J. Structure and reaction based evaluation of synthetic accessibility. J Comput Aided Mol Des. 2007 21 : 311 25.
94. Danziger DJ, Dean PM. Automated site-directed drug design: the prediction and observation of ligand point positions at hydrogen-bonding regions on protein surfaces. Proc R Soc Lond B Biol Sci. 1989 236 : 115 24.
95. Nishibata Y, Itai A. Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation. J Med Chem. 1993 36 : 2921 8.
96. Böhm HJ. On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure. J Comput Aided Mol Des. 1994 8 : 623 32.
97. Gillet V, Johnson AP, Mata P, Sike S, Williams P. SPROUT: A program for structure generation. J Comput Aided Mol Des. 1993 7 : 127 53.
98. Miranker A, Karplus M. An automated method for dynamic ligand design. Proteins. 1995 23 : 472 90.
99. Stultz CM, Karplus M. Dynamic ligand design and combinatorial optimization: designing inhibitors to endothiapepsin. Proteins. 2000 40 : 258 89.
100. DeWitte RS, Shakhnovich EI. SMoG: De novo design method based on simple, fast, and accurate free energy estimates. 1. Methodology and Supporting Evidence. J. Am. Chem. Soc. 1996 118 : 11733 44.
101. Roe DC, Kuntz ID. BUILDER v. 2: improving the chemistry of a de novo design strategy. J Comput Aided Mol Des. 1995 9 : 269 82.
102. Pearlman DA, Murcko MA. CONCERTS: dynamic connection of fragments as an approach to de novo ligand design. J Med Chem. 1996 39 : 1651 63.
103. Liebeschuetz JW, Jones SD, Morgan PJ, Murray CW, Rimmer AD, Roscoe JME, Waszkowycz B, Welsh PM, Wylie WA, Young SC, Martin H, Mahler J, Brady L, Wilkinson K. PRO-SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors. J Med Chem. 2002 45 : 1221 32.
104. Murray CW, Clark DE, Auton TR, Firth MA, Li J, Sykes RA, Waszkowycz B, Westhead DR, Young SC. PRO-SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology. J Comput Aided Mol Des. 1997 11 : 193 207.
105. Todorov N, Dean PM. Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design. J Comput Aided Mol Des. 1997 11 : 175 92.
106. Schneider G, Lee ML, Stahl M, Schneider PJ. De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks. J Comput Aided Mol Des. 2000 14 : 487 94.
107. Pegg SC, Haresco JJ, Kuntz ID. A genetic algorithm for structure-based de novo design. J Comput Aided Mol Des. 2001 15 : 911 33.
108. Brown N, McKay B, Gilardoni F, Gasteiger J. A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules. J Chem Inf Comput Sci. 2004 44 : 1079 87.
109. Green NM. Avidin. Adv Protein Chem. 1975 29 : 85 133.